Showing 2,201 - 2,220 results of 2,794 for search 'GCHQ~', query time: 1.05s Refine Results
  1. 2201

    CLASSIFYING CATEGORY NAMES IN VIETNAMESE WIKIPEDIA by Tạ Hoàng Thắng

    Published 2017-06-01
    “…Tạp chí Khoa học Đại học Đà Lạt…”
    Get full text
    Article
  2. 2202
  3. 2203
  4. 2204

    FURTHER IMPROVED CRITERION FOR EXPONENTIAL STABILITY OF LINEAR SYSTEMS WITH MULTIPLE TIME DELAYS by Phan Thanh Nam

    Published 2012-09-01
    “…Tạp chí Khoa học Đại học Đà Lạt…”
    Get full text
    Article
  5. 2205
  6. 2206
  7. 2207
  8. 2208
  9. 2209
  10. 2210
  11. 2211
  12. 2212
  13. 2213

    Precision fetal cardiology detects cyanotic congenital heart disease using maternal saliva metabolome and artificial intelligence by Ray Bahado-Singh, Nadia Ashrafi, Amin Ibrahim, Buket Aydas, Ali Yilmaz, Perry Friedman, Stewart F. Graham, Onur Turkoglu

    Published 2025-01-01
    “…Six different AI platforms were utilized for the detection of CCHD and CHD overall. AI achieved excellent accuracy for the CCHD detection: Area Under the ROC curve: AUC (95% CI) = 0.819 (0.635-1.00) with a sensitivity and specificity of 92.5% and 87.0%, and for CHD overall: AUC (95% CI) = 0.828 (0.635-1.00) with a sensitivity of 90.5% and specificity of 88.0%. …”
    Get full text
    Article
  14. 2214

    Pheochromocytoma in Congenital Cyanotic Heart Disease by Carmen Aresta, Gianfranco Butera, Antonietta Tufano, Giorgia Grassi, Livio Luzi, Stefano Benedini

    Published 2018-01-01
    “…Several cases of P-PGL have been reported in patients with cyanotic congenital heart disease (CCHD). Patients affected with CCHD have an increased likelihood of P-PGL compared to those affected with noncyanotic congenital heart disease. …”
    Get full text
    Article
  15. 2215
  16. 2216
  17. 2217

    Delirium Accompanied by Cholinergic Deficiency and Organ Failure in a 73-Year-Old Critically Ill Patient: Physostigmine as a Therapeutic Option by Benedikt Zujalovic, Eberhard Barth

    Published 2015-01-01
    “…We identified the altered AChE activity as a plausible pathophysiological mechanism. …”
    Get full text
    Article
  18. 2218

    Potential Azo-8-hydroxyquinoline derivatives as multi-target lead candidates for Alzheimer's disease: An in-depth in silico study of monoamine oxidase and cholinesterase inhibitors... by Fatima Zahra Guerguer, Bouchra Rossafi, Oussama Abchir, Yasir S Raouf, Dhabya Bakhit Albalushi, Abdelouahid Samadi, Samir Chtita

    Published 2025-01-01
    “…An exhaustive in silico analysis was conducted, encompassing docking studies, ADMET analysis, density functional theory (DFT) studies, molecular dynamics simulations, and subsequent MM-GBSA calculations to examine the pharmacological potential of these molecules with the specific targets of interest. Out of the 63 Azo-8HQ derivatives analysed, two molecules, 14c and 17c, demonstrated strong affinities for AChE, BuChE, and MAO-B, along with favourable pharmacokinetic profiles and electronic properties. …”
    Get full text
    Article
  19. 2219

    Acute Toxicity and Neuroprotective Effect of “RJ6601”, a Newly Formulated Instant Soup, in Geriatric Rats by Rujikarn Chaisanam, Jintanaporn Wattanathorn

    Published 2025-01-01
    “…At the end of the study period, assessments were conducted to evaluate the neuron density; MDA levels; and activities of SOD, CAT, GSH-Px, AChE, total MAO, MAO-A, and MAO-B in the hippocampus. …”
    Get full text
    Article
  20. 2220

    Recent advances in small molecule LpxC inhibitors against gram-negative bacteria (2014–2024) by Pengpeng Ji, Meng Ma, Xiaoyue Geng, Jian Zhang

    Published 2025-02-01
    “…Since the first report of the arazoline LpxC inhibitor L-573, 655, a large number of small molecule LpxC inhibitors against Gram-negative bacteria have been synthesized and tested, such as TU-514, CHIR-090, ACHN-975 and TP0586532. However, only ACHN-975 entered clinical phase I trials and was discontinued due to safety concerns, so far none of the LpxC inhibitors are available. …”
    Get full text
    Article